Grant Verstandig
Showing 1–2 of 2 transcripts.
- Milken Institute1h 0m
The Global Landscape and Opportunities for Medical Breakthroughs | Global Conference 2025
Usha Lee McFarling, Jay Bradner, Doug Drysdale, Neil Kumar, Alice Pomponio, Grant Verstandig
Biomedicine leaders from BridgeBio, Amgen, and Zephyr AI outlined a strategy to accelerate the industry from discovery to commercialization by leveraging precision diagnostics, population-scale genetics, and AI-driven protein folding to overcome the "valley of death." While startups like Saiban pioneer high-efficacy mental health treatments and the American Cancer Society launches "BrightEdge" to blend venture capital with donor funds, panelists warned that eroding NIH funding threatens this innovation ecosystem. The discussion emphasized that sustaining global competitiveness requires public-private partnerships to fund basic research and expand diverse genomic databases beyond Western populations.
- Milken Institute40 min
AI: A Multiplier or a Divider? | Middle East and Africa Summit 2024
Sarah Yaseen, Nicole Valentine, Prem Akkaraju, Kate Kallot, Rohan Patel, Grant Verstandig
Leading AI practitioners including Prem Sacharczyk, Kate Turrell, and Rohan Seth convened to analyze the projected $4.4 trillion capital influx into global sectors while debating strategic frameworks for ethical deployment and workforce adaptation. The panelists utilized historical figures to illustrate their visions for AI's role in balancing creative liberation against risks like asymmetric power and the erosion of junior skill acquisition. Ultimately, the discussion emphasized immediate self-regulation through sanitized data practices and infrastructure investment in emerging markets to mitigate potential harms while accelerating innovation in science and industry.